This website uses cookies files. By continuing to browse this site you are agreeing to our cookies policy Cookie policy

You are here: Home InvestmentsEquity funds Esaliens Medicine & New Technology (until 19.10.2021 Esaliens Strategist)

Esaliens Medicine & New Technology (until 19.10.2021 Esaliens Strategist)

A subfund of ESA Umbrella OEIF The subfund is available within products with tax preferences

Subfund's details

Subfund type 
Equity subfund
Incepition date
4 January 1999
Minimum investment
PLN 100
Maximum initial fee (A units)
Management fee (A units)

Benchmark portfolio (for variable management remuneration)
90% MSCI World Health Care Index + 10% WIRON

MSCI disclaimer

Variable management fee

20% of the fund performance above the change from the benchmark portfolio over a one-year settlement period. Details available in the Fund's prospectus.

Account No. for purchases
70 1050 0086 1000 0090 3004 5067

This is an advertising information. Past performance does not indicate future returns.

Performance chart

The chart presents performance of class A unitsInvest online
Selected dates scope:

Error occured,

Try again later.



Period ESA Medicine & New Technology
1 month -2.14%
3 months 4.36%
6 months 14.09%
12 months -4.80%
36 months -20.44%
60 months -9.18%
120 months -24.10%
YTD 6.83%
* Performance of class A units, 22-04-2024
2015: -11,68%, 2016: -2,13%, 2017: 6,59%, 2018: -10,25%, 2019: 6,34%, 2020: 6,80%, 2021: 12,32%

Risk profile

4 - high risk

Risk indicator is presented in accordance with the Key Information Document. The indicator is calculated based on the historical volatility of the fund's rates of return resulting from the implemented investment policy and may change in the future. Even the lowest risk category does not mean that the fund is risk-free. Other risk factors related to investing in the fund, which are not included in the indicator, are presented in the Key Information Document and the Fund's Prospectus.

asset allocation

Model allocation - up to 100% of subfund's portfolio invested in shares.

Investor's profile

The subfund is designed for an investor who:

  • expects to achieve a rate of return on investment in shares of companies whose activities are related to health protection or new technologies. 
  • accepts high investment risk,
  • is looking for a fund with an active, selective management style (careful selection of valuable enterprises),
  • avoids market-timing strategy (forecasting stock market trends and building portfolios for the short-term expected and anticipated event scenario),
  • is looking for a wide diversification of the portfolio of companies, minimizing the risk of a single company.
The subfund is designed i.a. for regular investing within long-term saving and pension schemes (regular saving plans (CPO), individual retirement accounts (IKE), individual pension security accounts (IKZE), occupational pension schemes (PPE)).
The evaluation of fund’s performance should not be made for a period shorter than 3 years.

additional information

Transfer Agent

Pekao Financial Services Sp. z o.o.


ING Bank Śląski S.A. w Katowicach

Investment Process

ESALIENS Medicine & New Technology Subfund invests from 60% to 100% of its assets in equity securities of companies listed on the regulated market. As a part of the investment objective, the Fund invests primarily in shares of companies whose activities are related to health protection or new technologies, as well as other types of investments.

The Fund may invest the Subfund's Assets in other investments, in particular debt securities or Money Market Instruments, in order to ensure the Subfund's liquidity and minimize the risk of impairment of the Shares in periods of downturn on the stock market.

The sub-fund is actively managed.


ESALIENS Medicine & New Technology - Fact card 194.88 KB

The fund complies

Subscribe to daily prices

Subscribe to daily prices

Investor's giude

Esaliens Medicine & New Technology

Start investing now!

Invest online

Important information

This is an advertising information. This material does not contain sufficient information to make an investment decision. The promoted investment means the purchase of participation units.

The fund do not guarantee that the investment objective or a specific investment result will be achieved. Before investing, you should read the Prospectus and the Key Information Documents. The Prospectus as well as the Key Information Documents include the data required to evaluate an investment, outline the risks connected with participation in the fund, and inform on the related costs, charges and taxes. Read the full text of the important information


Esaliens24 application for you
Monitor your savings and control your investment portfolio

go up